World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
81
Citations
21174
World Ranking
1584
National Ranking
789

Larry S. Schlesinger publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Larry S. Schlesinger sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 270 publications — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Larry S. Schlesinger D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Larry S. Schlesinger sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 81 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Larry S. Schlesinger is affiliated with the Texas Biomedical Research Institute in the United States. Their research primarily focuses on medicine, with a significant emphasis on immunology and microbiology. Within these fields, the scientist has extensively studied infectious diseases, immunology, molecular biology, epidemiology, and pulmonary and respiratory medicine.

The central topics addressed in their work include:

  • Tuberculosis Research and Epidemiology
  • SARS-CoV-2 and COVID-19 Research
  • Immune cells in cancer
  • COVID-19 Clinical Research Studies
  • Mycobacterium research and diagnosis
  • Long-Term Effects of COVID-19
  • Neonatal Respiratory Health Research

The scientist has published in several venues, with a notable presence in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • Nature Microbiology
  • The Journal of Immunology
  • UNC Libraries

Selected recent papers authored or co-authored by Larry S. Schlesinger include:

  • "Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice," 2020, Nature Communications
  • "Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets," 2020, Nature Microbiology
  • "IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection," 2021, Communications Biology
  • "Myeloid cell interferon responses correlate with clearance of SARS-CoV-2," 2022, Nature Communications
  • "Lethality of SARS-CoV-2 infection in K18 human angiotensin converting enzyme 2 transgenic mice," 2020, bioRxiv (Cold Spring Harbor Laboratory)

Frequent collaborators in their work include:

  • Jordi B. Torrelles
  • Eusondia Arnett
  • Deepak Kaushal
  • Joanne Turner
  • Andreu Garcia-Vilanova

Best Publications

  • Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors.

    L S Schlesinger

  • Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3.

    L S Schlesinger;C G Bellinger-Kawahara;N R Payne;M A Horwitz

  • The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis

    Peter B. Kang;Abul K. Azad;Jordi B. Torrelles;Thomas M. Kaufman

  • Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages.

    L S Schlesinger;S R Hull;T M Kaufman

  • Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages.

    C D Gaynor;F X McCormack;D R Voelker;S E McGowan

  • Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice.

    Fatai S. Oladunni;Jun-Gyu Park;Paula A. Pino;Olga Gonzalez

  • Macrophages in tuberculosis: friend or foe.

    Evelyn Guirado;Larry S. Schlesinger;Gilla Kaplan

  • Innate Immune Gene Polymorphisms in Tuberculosis

    Abul K. Azad;Wolfgang Sadee;Larry S. Schlesinger

  • Mycobacterium tuberculosis lipomannan blocks TNF biosynthesis by regulating macrophage MAPK-activated protein kinase 2 (MK2) and microRNA miR-125b

    Murugesan V. S. Rajaram;Bin Ni;Jessica D. Morris;Michelle N. Brooks

  • Modeling the Mycobacterium tuberculosis Granuloma - the Critical Battlefield in Host Immunity and Disease.

    Evelyn Guirado;Larry S. Schlesinger

  • Surfactant Protein D Binds to Mycobacterium tuberculosis Bacilli and Lipoarabinomannan via Carbohydrate-Lectin Interactions Resulting in Reduced Phagocytosis of the Bacteria by Macrophages1

    Ferguson Js;Voelker Dr;McCormack Fx;Schlesinger Ls

  • Expression and localization of hepcidin in macrophages: a role in host defense against tuberculosis.

    Fatoumata B. Sow;William C. Florence;Abhay R. Satoskar;Larry S. Schlesinger

  • Pseudomonas aeruginosa Psl polysaccharide reduces neutrophil phagocytosis and the oxidative response by limiting complement-mediated opsonization.

    Meenu Mishra;Matthew S. Byrd;Susan Sergeant;Abul K. Azad

  • Mycobacterium tuberculosis Activates Human Macrophage Peroxisome Proliferator-Activated Receptor γ Linking Mannose Receptor Recognition to Regulation of Immune Responses

    Murugesan V. S. Rajaram;Michelle N. Brooks;Jessica D. Morris;Jordi B. Torrelles

  • Virulent Strains of Helicobacter pylori Demonstrate Delayed Phagocytosis and Stimulate Homotypic Phagosome Fusion in Macrophages

    Lee-Ann H. Allen;Larry S. Schlesinger;Byoung Kang

  • Gallium Disrupts Iron Metabolism of Mycobacteria Residing within Human Macrophages

    Oyebode Olakanmi;Bradley E. Britigan;Larry S. Schlesinger

  • Exploitation of the Macrophage Mannose Receptor (CD206) in Infectious Disease Diagnostics and Therapeutics.

    Abul K. Azad;Murugesan V. S. Rajaram;Larry S. Schlesinger

  • Differences in mannose receptor-mediated uptake of lipoarabinomannan from virulent and attenuated strains of Mycobacterium tuberculosis by human macrophages.

    L S Schlesinger;T M Kaufman;S Iyer;S R Hull

  • Fine discrimination in the recognition of individual species of phosphatidyl-myo-inositol mannosides from Mycobacterium tuberculosis by C-type lectin pattern recognition receptors.

    Jordi B. Torrelles;Abul K. Azad;Larry S. Schlesinger

  • Phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages is mediated by complement receptors CR1 (CD35), CR3 (CD11b/CD18), and CR4 (CD11c/CD18) and IFN-gamma activation inhibits complement receptor function and phagocytosis of this bacterium.

    L S Schlesinger;M A Horwitz

  • Human Genetic Determinants of Viral Diseases.

    Adam D. Kenney;James A. Dowdle;Leonia Bozzacco;Leonia Bozzacco;Temet M. McMichael

  • Lethality of SARS-CoV-2 infection in K18 human angiotensin converting enzyme 2 transgenic mice

    Fatai S. Oladunni;Jun-Gyu Park;Paula Pino Tamayo;Olga Gonzalez

Frequent Co-Authors

John S. Gunn
John S. Gunn Nationwide Children's Hospital
Joanne Turner
Joanne Turner Texas Biomedical Research Institute
Bradley E. Britigan
Bradley E. Britigan University of Nebraska Medical Center
Wolfgang Sadee
Wolfgang Sadee The Ohio State University
Susheela Tridandapani
Susheela Tridandapani The Ohio State University
Ching-Shih Chen
Ching-Shih Chen The Ohio State University
Francis X. McCormack
Francis X. McCormack University of Cincinnati
Shabaana A. Khader
Shabaana A. Khader Washington University in St. Louis
Mark D. Wewers
Mark D. Wewers The Ohio State University
Avner Friedman
Avner Friedman The Ohio State University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in the field of Immunology, a variety of related online degrees offer practical career pathways in healthcare and research. Many students begin with foundational nursing programs that provide essential clinical skills and a deep understanding of human biology.

Non-nurses looking to transition into healthcare may find best online BSN programs for non nurses particularly valuable. These programs are designed to be accessible for individuals without prior nursing experience, enabling a streamlined entry into this dynamic field.

Accelerated options like the easiest ABSN to get into can speed up the path to becoming a registered nurse by condensing coursework and clinical practice into an intensive format. These programs are ideal for students eager to enter the workforce quickly.

For those starting at the practical nursing level, exploring the best easiest LPN programs to get into offers a straightforward pathway to patient care roles. Licensed Practical Nurses often work closely with immunology patients in clinical settings.

Advancing further, nurse practitioners play a critical role in specialized healthcare delivery. Identifying nurse practitioner programs with easy admission can provide a smoother transition into advanced practice roles that intersect with immunological research and patient management.

Best Scientists Citing Larry S. Schlesinger

Trending Scientists

Recently Published Articles